BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zhu ZZ, Cong WM, Liu SF, Dong H, Zhu GS, Wu MC. Homozygosity for Pro of p53 Arg72Pro as a potential risk factor for hepatocellular carcinoma in Chinese population. World J Gastroenterol 2005; 11(2): 289-292 [PMID: 15633234 DOI: 10.3748/wjg.v11.i2.289]
URL: https://www.wjgnet.com/1007-9327/full/v11/i2/289.htm
Number Citing Articles
1
Xi Dai Long, Yun Ma, Hong Dong Huang, Jin Guang Yao, De Ying Qu, Yun Long Lu. Polymorphism of XRCC1 and the frequency of mutation in codon 249 of the p53 gene in hepatocellular carcinoma among guangxi population, ChinaMolecular Carcinogenesis 2008; 47(4): 295 doi: 10.1002/mc.20384
2
Tomasz Zemleduch, Margarita Lianeri, Małgorzata Rydzanicz, Marzena Gajęcka, Krzysztof Szyfter, Paweł P. Jagodziński. Contribution of polymorphism in codon 72 of TP53 gene to laryngeal cancer in Polish patientsOral Oncology 2009; 45(8): 683 doi: 10.1016/j.oraloncology.2008.10.009
3
Jyh-Der Leu, I-Feng Lin, Ying-Fang Sun, Su-Mei Chen, Chih-Chao Liu, Yi-Jang Lee. Association between MDM2-SNP309 and hepatocellular carcinoma in Taiwanese populationWorld Journal of Gastroenterology 2009; 15(44): 5592-5597 doi: 10.3748/wjg.15.5592
4
Chang-Tao Xu, Fang Zheng, Xin Dai, Ji-Dong Du, Hao-Run Liu, Li Zhao, Wei-Min Li. Association Between TP53 Arg72Pro Polymorphism and Hepatocellular Carcinoma Risk: A Meta-analysisAsian Pacific Journal of Cancer Prevention 2012; 13(9): 4305 doi: 10.7314/APJCP.2012.13.9.4305
5
Ze Tian, Geng Lin, Rui-Xia Zheng, Feng Huang, Meng-Su Yang, Pei-Gen Xiao. Anti-hepatoma activity and mechanism of ursolic acid and its derivatives isolated from Aralia decaisneanaWorld Journal of Gastroenterology 2006; 12(6): 874-879 doi: 10.3748/wjg.v12.i6.874
6
Ayse Engin, Bensu Karahalil, Ali Karakaya, Atilla Engin. Association Between XRCC1 ARG399GLN and P53 ARG72PRO Polymorphisms and the Risk of Gastric and Colorectal Cancer in Turkish PopulationArchives of Industrial Hygiene and Toxicology 2011; 62(3): 207 doi: 10.2478/10004-1254-62-2011-2098
7
Khadija Rebbani, Agnès Marchio, Sayeh Ezzikouri, Rajaa Afifi, Mostafa Kandil, Olfa Bahri, Henda Triki, Abdellah Essaid El Feydi, Anne Dejean, Soumaya Benjelloun, Pascal Pineau. TP53 R72P polymorphism modulates DNA methylation in hepatocellular carcinomaMolecular Cancer 2015; 14(1) doi: 10.1186/s12943-015-0340-2
8
Maria Teresa Vietri, Gabriele Riegler, Antonietta Ursillo, Luigi Caserta, Michele Cioffi, Anna Maria Molinari. p53 codon 72 polymorphism in patients affected with ulcerative colitisJournal of Gastroenterology 2007; 42(6): 456 doi: 10.1007/s00535-007-2026-z
9
Moqin Qiu, Yingchun Liu, Xiangyuan Yu, Linyuan Qin, Chunhua Bei, Xiaoyun Zeng, Xiaoqiang Qiu, Bo Tang, Songqing He, Hongping Yu. Interaction between p53 codon 72 and MDM2 309T>G polymorphisms and the risk of hepatocellular carcinomaTumor Biology 2016; 37(3): 3863 doi: 10.1007/s13277-015-4222-4
10
Surong Hu, Lianying Zhao, Jingting Yang, Miao Hu. The association between polymorphism of P53 Codon72 Arg/Pro and hepatocellular carcinoma susceptibility: evidence from a meta-analysis of 15 studies with 3,704 casesTumor Biology 2014; 35(4): 3647 doi: 10.1007/s13277-013-1483-7
11
Yanmei Zou, Hua Xiong, Huihua Xiong, Tao Lu, Feng Zhu, Zhiyong Luo, Xianglin Yuan, Yihua Wang. A polysaccharide from Andrographis paniculata induces mitochondrial-mediated apoptosis in human hepatoma cell line (HepG2)Tumor Biology 2015; 36(7): 5179 doi: 10.1007/s13277-015-3172-1
12
D. Grotemeyer, S. Pourhassan, W. Sandmann. Paradigmenwechsel in der Behandlung des Wilkie-SyndromsDer Internist 2009; 50(4): 484 doi: 10.1007/s00108-008-2263-0
13
C Ding, H Yu, H Yu, H Qin. TP53 Codon 72 Polymorphism with Hepatocellular Carcinoma: A Meta-AnalysisJournal of International Medical Research 2012; 40(2): 446 doi: 10.1177/147323001204000206
14
Seok Won Jung, Neung Hwa Park, Jung Woo Shin, Bo Ryung Park, Chang Jae Kim, Jong-Eun Lee, Eun-Soon Shin, Jeong A Kim, Young-Hwa Chung. Polymorphisms of DNA repair genes in Korean hepatocellular carcinoma patients with chronic hepatitis B: Possible implications on survivalJournal of Hepatology 2012; 57(3): 621 doi: 10.1016/j.jhep.2012.04.039
15
Surong Hu, Lianying Zhao, Jingting Yang, Miao Hu. The association between polymorphism of P53 codon 72 Arg/Pro and hepatocellular carcinoma susceptibility: evidence from a meta-analysis of 15 studies with 3704 casesMeta Gene 2013; 1: 126 doi: 10.1016/j.mgene.2013.09.010
16
Narayan Dharel, Naoya Kato, Ryosuke Muroyama, Masaru Moriyama, Run-Xuan Shao, Takao Kawabe, Masao Omata. MDM2 Promoter SNP309 Is Associated with the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis CClinical Cancer Research 2006; 12(16): 4867 doi: 10.1158/1078-0432.CCR-06-0111
17
Luis Orlando Pérez, Martin Carlos Abba, Fernando Noel Dulout, Carlos Daniel Golijow. Evaluation of p53 codon 72 polymorphism in adenocarcinomas of the colon and rectum in La Plata, ArgentinaWorld Journal of Gastroenterology 2006; 12(9): 1426-1429 doi: 10.3748/wjg.v12.i9.1426
18
Ahmet Taner Sümbül, Hikmet Akkız, Süleyman Bayram, Aynur Bekar, Ersin Akgöllü, Macit Sandıkçı. p53 codon 72 polymorphism is associated with susceptibility to hepatocellular carcinoma in the Turkish population: a case–control studyMolecular Biology Reports 2012; 39(2): 1639 doi: 10.1007/s11033-011-0903-2
19
Ken C. Lo, Dione Bailey, Tania Burkhardt, Paul Gardina, Yaron Turpaz, John K. Cowell. Comprehensive analysis of loss of heterozygosity events in glioblastoma using the 100K SNP mapping arrays and comparison with copy number abnormalities defined by BAC array comparative genomic hybridizationGenes, Chromosomes and Cancer 2008; 47(3): 221 doi: 10.1002/gcc.20524
20
Xiaohua Duan, Jingquan Li. Association between MDM2 SNP309, p53 Arg72Pro, and hepatocellular carcinoma riskMedicine 2017; 96(36): e7856 doi: 10.1097/MD.0000000000007856
21
Mustafa A. Neamatallah, Mohamed Amr El-Missiry, Muhamad M.A. Said, Mahmoud Elbendary, Azza I. Othman, Omar A. Ammar. TP53 polymorphism as a risk factor for hepatocellular carcinoma in hepatitis C virus-infected Egyptian patientsEgyptian Journal of Basic and Applied Sciences 2014; 1(1): 9 doi: 10.1016/j.ejbas.2014.01.001
22
Y. J. Yoon, H. Y. Chang, S. H. Ahn, J. K. Kim, Y. K. Park, D. R. Kang, J. Y. Park, S. M. Myoung, D. Y. Kim, C. Y. Chon, K.-H. Han. MDM2 and p53 polymorphisms are associated with the development of hepatocellular carcinoma in patients with chronic hepatitis B virus infectionCarcinogenesis 2008; 29(6): 1192 doi: 10.1093/carcin/bgn090
23
Janet Edrington, Christine Miaskowski, Marylin Dodd, Candice Wong, Geraldine Padilla. A Review of the Literature on the Pain Experience of Chinese Patients With CancerCancer Nursing 2007; 30(5): 335 doi: 10.1097/01.NCC.0000290813.14571.65
24
Liu Liu, Kai Wang, Zheng-Ming Zhu, Jiang-Hua Shao. Associations Between P53 Arg72Pro and Development of Digestive Tract Cancers: A Meta-analysisArchives of Medical Research 2011; 42(1): 60 doi: 10.1016/j.arcmed.2011.01.008
25
K. N. Kashkin, S. V. Khlgatian, O. V. Gurova, D. V. Kuprash, S. A. Nedospasov. New mutations in the human p53 gene — a regulator of the cell cycle and carcinogenesisBiochemistry (Moscow) 2007; 72(3): 282 doi: 10.1134/S0006297907030054
26
Shu-Chun Chuang, Yuan-Chin Amy Lee, Guo-Jie Wu, Kurt Straif, Mia Hashibe. Alcohol consumption and liver cancer risk: a meta-analysisCancer Causes & Control 2015; 26(9): 1205 doi: 10.1007/s10552-015-0615-3
27
Seok Won Jung, Neung Hwa Park, Jung Woo Shin, Bo Ryung Park, Chang Jae Kim, Jong-Eun Lee, Eun-Soon Shin, Jeong A Kim, Young-Hwa Chung. Prognostic impact of telomere maintenance gene polymorphisms on hepatocellular carcinoma patients with chronic hepatitis BHepatology 2014; 59(5): 1912 doi: 10.1002/hep.26655